This feedback loop between liver dysfunction and systemic metabolic disturbances perpetuates and worsens hepatic insulin resistance, creating a vicious cycle of metabolic dysregulation that is central to the pathology of obesity-related liver diseases (Figure 1) [20,21]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.